Tinashe Chandauka

Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the aim to deliver benefit and value for all its stakeholders; patients, healthcare providers and investors. The world-leading science generated by its academic founders is the foundation for the development of therapeutic products based on the understanding of the molecular control of circadian rhythms. With an experienced leadership team and a track-record of building operational capabilities and delivering shareholder value, the Company will develop therapeutics targeting serious diseases associated with circadian rhythm disruption.

Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the aim to deliver benefit and value for all its stakeholders; patients, healthcare providers and investors. The world-leading science generated by its academic founders is the foundation for the development of therapeutic products based on the understanding of the molecular control of circadian rhythms. With an experienced leadership team and a track-record of building operational capabilities and delivering shareholder value, the Company will develop therapeutics targeting serious diseases associated with circadian rhythm disruption.

TMAB is developing first-in-class multi-specific antibodies targeting the solid tumor micro-environment.

Nandi is a rare disease, oncology and auto-immune biotechnology company. Our world-class team is uniquely comprised of pre-eminent scientists, MDs and PhDs with decades of experience in research and development, clinical medicine and commercialization. Our panel of strategic advisors consists of industry leading company creators with recent relevant operational experience in systemically important biotech and pharmaceutical corporations and deep networks in east and west coast life sciences venture capital hubs.

Why Amref Health Africa? Sub-Saharan Africa contends with a quarter of the world's disease burden, but has just 3% of the world's health workers. We are working to change this. Amref Health Africa is Africa's leading health charity and one of the leading healthcare development agencies on the continent. Working primarily with women and girls, our vision is of lasting health change within Africa's most vulnerable and remote communities. Headquartered in Nairobi, Kenya, we are a truly African organisation, which combines grass roots development with government partnerships. This ethos defines our community-based approach and echoes across each and every one of the projects and programmes we deliver. We started life in 1957 as the Flying Doctors of East Africa. Beginning with aeroplanes to provide the most remote communities with health care, we have always used the tools of our time to bridge the gap between heath systems and people. Today we use eLearning, telemedicine, and mobile phones to spread health knowledge and care. Our work has won high-profile international awards such as the Bill and Melinda Gates Foundation's Award for Global Health and the Conrad Hilton Humanitarian Award.

Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the aim to deliver benefit and value for all its stakeholders; patients, healthcare providers and investors. The world-leading science generated by its academic founders is the foundation for the development of therapeutic products based on the understanding of the molecular control of circadian rhythms. With an experienced leadership team and a track-record of building operational capabilities and delivering shareholder value, the Company will develop therapeutics targeting serious diseases associated with circadian rhythm disruption.